Zytiga 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Johnson & Johnson Pvt Ltd
  4. Zytiga 250 mg Tablet

Zytiga 250 mg Tablet

Zytiga 250 mg Tablet contains abiraterone acetate 250 mg, an oral androgen biosynthesis inhibitor used in prostate cancer treatment. It is used for advanced prostate cancer, including metastatic castration-resistant and high-risk metastatic castration-sensitive disease. The tablet is a prescription medicine and is generally used with a corticosteroid under specialist medical supervision.

BUY NOW

Category

Abiraterone blocks the CYP17 enzyme, reducing androgen production in the testes, adrenal glands, and prostate tumor tissue. This lowers hormonal stimulation that can support the growth of prostate cancer cells. Zytiga 250 mg should be taken on an empty stomach, at least one hour before or two hours after food, as food can increase abiraterone exposure. Treatment requires medical monitoring because it can affect blood pressure, potassium levels, liver function, and fluid balance.

Technical Specification

Specification Details
Active Ingredient Abiraterone Acetate
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 120 tablets
Manufacturer / Marketer Johnson & Johnson Pvt Ltd

Product Also Known As

Zytiga 250mg Tablet, Zytiga 250 mg Tablet, Zytiga 250 Tablet, Abiraterone Acetate 250mg Tablet, Abiraterone Acetate 250 mg Tablet, Abiraterone 250mg Tablet, Abiraterone Prostate Cancer Tablet

Related products